|Articles|February 1, 2016
- BioPharm International-02-01-2016
- Volume 28
- Issue 2
BioPharm International, February 2016 Issue (PDF)
Click the title above to open the BioPharm International February 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 10 years ago
Antibody Production in Microbial Hostsabout 10 years ago
Advances in Assay Technologies for CAR T-Cell Therapiesabout 10 years ago
Innovative Therapies Require Modern Manufacturing Systemsabout 10 years ago
Macro Mattersabout 10 years ago
Fine Tuning the Focus on Biopharma Analytical Studiesabout 10 years ago
Biopharma Innovation Born Again?about 10 years ago
Failure Mode Effects Analysis for Filter Integrity Testingabout 10 years ago
The Emerging View of Endotoxin as an IIRMIabout 10 years ago
Use of an E. coli pgi Knockout Strain as a Plasmid ProducerNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
3
Industry Outlook 2026: Key Forces Transforming Drug Pipelines (Part 2)
4
Eli Lilly Announces New $3.5 Billion Manufacturing Facility in Pennsylvania
5
